Prospera clinical trials

Trifecta-Kidney cfDNA-MMDx Study

This study looks at new ways to check for rejection in kidney transplant patients. It compares a new blood test (DD-cfDNA) with a special biopsy test (MMDx) and traditional checks to see which is best at finding rejection accurately.